Methods and compositions for the treatment of epidermolysis bullosa
US10960045B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 14, 2016 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Oct 14, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating epidermolysis bullosa comprising administering to a subject suffering from epidermolysis bullosa an angiotensin (1-7) peptide is described. In some embodiments, methods of treating a complication of epidermolysis bullosa are described including administering to a subject suffering from one or more complications of epidermolysis bullosa an angiotensin (1-7) peptide, wherein the administration results in a reduction in the intensity, severity, duration, or frequency of at least one symptom or feature of the one or more complications of epidermolysis bullosa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.